Evidence map›Paper›PMID 26192618›Full record

ArticleOncogenesis2015

Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps.

I Kuperstein, E Bonnet, H-A Nguyen, D Cohen, E Viara, L Grieco, S Fourquet, L Calzone, C Russo, M Kondratova and 3 more

Open access · goldAbstract read
In one paragraph

Article in Oncogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

I Kuperstein1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
E Bonnet1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
H-A Nguyen1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
D Cohen1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
E ViaraSysra, Paris, France.
L Grieco1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France [4] Ecole Normale Supérieure, IBENS, Paris, France [5] CNRS, UMR8197, Paris, France [6] INSERM, U1024, Paris, France.
S Fourquet1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
L Calzone1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
C Russo1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
M Kondratova1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
M Dutreix1] Institut Curie, Paris, France [2] CNRS, UMR3347, Orsay, France [3] INSERM, U1021, Orsay, France.
E Barillot1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
A Zinovyev1] Institut Curie, Paris, France [2] INSERM, U900, Paris, France [3] Mines ParisTech, Fontainebleau, France.
Inserm · FRInstitut Curie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancerogenesis is driven by mutations leading to aberrant functioning of a complex network of molecular interactions and simultaneously affecting multiple cellular functions. Therefore, the successful application of bioinformatics and systems biology methods for analysis of high-throughput data in cancer research heavily depends on availability of global and detailed reconstructions of signalling networks amenable for computational analysis. We present here the Atlas of Cancer Signalling Network (ACSN), an interactive and comprehensive map of molecular mechanisms implicated in cancer. The resource includes tools for map navigation, visualization and analysis of molecular data in the context of signalling network maps. Constructing and updating ACSN involves careful manual curation of molecular biology literature and participation of experts in the corresponding fields. The cancer-oriented content of ACSN is completely original and covers major mechanisms involved in cancer progression, including DNA repair, cell survival, apoptosis, cell cycle, EMT and cell motility. Cell signalling mechanisms are depicted in detail, together creating a seamless 'geographic-like' map of molecular interactions frequently deregulated in cancer. The map is browsable using NaviCell web interface using the Google Maps engine and semantic zooming principle. The associated web-blog provides a forum for commenting and curating the ACSN content. ACSN allows uploading heterogeneous omics data from users on top of the maps for visualization and performing functional analyses. We suggest several scenarios for ACSN application in cancer research, particularly for visualizing high-throughput data, starting from small interfering RNA-based screening results or mutation frequencies to innovative ways of exploring transcriptomes and phosphoproteomes. Integration and analysis of these data in the context of ACSN may help interpret their biological significance and formulate mechanistic hypotheses. ACSN may also support patient stratification, prediction of treatment response and resistance to cancer drugs, as well as design of novel treatment strategies.

Identifiers

PMID26192618
PMCPMC4521180
OpenAlexW893557411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.